Diisopropylcarbodiimide → [2-(ethyldisulfanyl)-6-methylphenyl] (3S)-3-[[(2S)-2-[[(2S)-3-methyl-2-[methyl-[(2S)-4-methyl-2-[methyl-[2-[[(2S)-2-[methyl-[(2S,3R)-2-[[(2S)-4-methyl-2-[methyl-[(2S)-3-methyl-2-[[(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]amino]butanoyl]amino]pentanoyl]amino]-3-trityloxybutanoyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]pentanoyl]amino]butanoyl]amino]-3-phenylpropanoyl]amino]-4-[methyl-[(2S)-1-oxo-1-[[(2S)-1-oxo-1-piperidin-1-ylpropan-2-yl]amino]-3-phenylpropan-2-yl]amino]-4-oxobutanoate
Reaction equation
[CH2:1]([S:3][S:4][C:5]1[CH:10]=[CH:9][CH:8]=[C:7]([CH3:11])[C:6]=1[OH:12])[CH3:2].C(=NC(C)C)=NC(C)C.[CH2:22]([C@@H:29]([C:86](=[O:150])[NH:87][CH2:88][C:89](=[O:149])[N:90]([CH3:148])[C@@H:91]([CH2:144][CH:145]([CH3:147])[CH3:146])[C:92](=[O:143])[N:93]([CH3:142])[C@@H:94]([CH:139]([CH3:141])[CH3:140])[C:95](=[O:138])[NH:96][C@@H:97]([CH2:131][C:132]1[CH:137]=[CH:136][CH:135]=[CH:134][CH:133]=1)[C:98](=[O:130])[NH:99][C@H:100]([C:105](=[O:129])[N:106]([CH3:128])[C@@H:107]([CH2:121][C:122]1[CH:127]=[CH:126][CH:125]=[CH:124][CH:123]=1)[C:108](=[O:120])[NH:109][C@@H:110]([CH3:119])[C:111](=[O:118])[N:112]1[CH2:117][CH2:116][CH2:115][CH2:114][CH2:113]1)[CH2:101][C:102](O)=[O:103])[N:30]([CH3:85])[C:31](=[O:84])[C@H:32]([C@H:62]([O:64][C:65]([C:78]1[CH:83]=[CH:82][CH:81]=[CH:80][CH:79]=1)([C:72]1[CH:77]=[CH:76][CH:75]=[CH:74][CH:73]=1)[C:66]1[CH:71]=[CH:70][CH:69]=[CH:68][CH:67]=1)[CH3:63])[NH:33][C:34](=[O:61])[C@H:35]([CH2:57][CH:58]([CH3:60])[CH3:59])[N:36]([CH3:56])[C:37](=[O:55])[C@H:38]([CH:52]([CH3:54])[CH3:53])[NH:39][C:40](=[O:51])[C@H:41]([CH3:50])[NH:42][C:43](=[O:49])[O:44][C:45]([CH3:48])([CH3:47])[CH3:46])[C:23]1[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=1>CN(C)C1C=CN=CC=1.ClCCl>[CH2:22]([C@@H:29]([C:86](=[O:150])[NH:87][CH2:88][C:89](=[O:149])[N:90]([CH3:148])[C@@H:91]([CH2:144][CH:145]([CH3:147])[CH3:146])[C:92](=[O:143])[N:93]([CH3:142])[C@@H:94]([CH:139]([CH3:141])[CH3:140])[C:95](=[O:138])[NH:96][C@@H:97]([CH2:131][C:132]1[CH:137]=[CH:136][CH:135]=[CH:134][CH:133]=1)[C:98](=[O:130])[NH:99][C@H:100]([C:105](=[O:129])[N:106]([CH3:128])[C@@H:107]([CH2:121][C:122]1[CH:123]=[CH:124][CH:125]=[CH:126][CH:127]=1)[C:108](=[O:120])[NH:109][C@@H:110]([CH3:119])[C:111](=[O:118])[N:112]1[CH2:117][CH2:116][CH2:115][CH2:114][CH2:113]1)[CH2:101][C:102]([O:12][C:6]1[C:7]([CH3:11])=[CH:8][CH:9]=[CH:10][C:5]=1[S:4][S:3][CH2:1][CH3:2])=[O:103])[N:30]([CH3:85])[C:31](=[O:84])[C@H:32]([C@H:62]([O:64][C:65]([C:66]1[CH:71]=[CH:70][CH:69]=[CH:68][CH:67]=1)([C:72]1[CH:73]=[CH:74][CH:75]=[CH:76][CH:77]=1)[C:78]1[CH:83]=[CH:82][CH:81]=[CH:80][CH:79]=1)[CH3:63])[NH:33][C:34](=[O:61])[C@H:35]([CH2:57][CH:58]([CH3:60])[CH3:59])[N:36]([CH3:56])[C:37](=[O:55])[C@H:38]([CH:52]([CH3:54])[CH3:53])[NH:39][C:40](=[O:51])[C@H:41]([CH3:50])[NH:42][C:43](=[O:49])[O:44][C:45]([CH3:46])([CH3:47])[CH3:48])[C:23]1[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
2-(Ethyldisulfanyl)-6-methylphenol separately synthesized according to a conventional method (J. AM. CHEM. SOC. 2009, 131, 5432-5437) (10.3 mg, 0.051 mmol), N,N′-methanediylidenebis(propan-2-amine) (8.0 ul, 0.051 mmol) and N,N-dimethylpyridin-4-amine (4.2 mg, 0.034 mmol) were added to a solution of (6S,9S,12S,15S,18S,24S,27S,30S,33S)-18,30-dibenzyl-12,24-diisobutyl-9,27-diisopropyl-2,2,6,11,17,23,26-heptamethyl-33-(methyl((S)-1-oxo-1-(((S)-1-oxo-1-(piperidin-1-yl)propan-2-yl)amino)-3-phenylpropan-2-yl)carbamoyl)-4,7,10,13,16,19,22,25,28,31-decaoxo-15-((R)-1-(trityloxy)ethyl)-3-oxa-5,8,11,14,17,20,23,26,29,32-decaazapentatriacontan-35-oic acid (Boc-Ala-Val-MeLeu-Thr(Trt)-MePhe-Gly-MeLeu-MeVal-Phe-Asp-MePhe-Ala-piperidine, 60.9 mg, 0.034 mmol) synthesized by peptide synthesis by the Fmoc method previously described using Boc amino acid in place of Fmoc amino acid at the N-terminal in dichloromethane (300 ul), and the mixture was stirred at room temperature overnight. The reaction solution was then concentrated under reduced pressure and purified by reverse phase silica gel column chromatography (10 mM aqueous ammonium acetate solution/methanol=70/30→0/100) to afford 2-(ethyldisulfanyl)-6-methylphenyl (6S,9S,12S,15S,18S,24S,27S,30S,33S)-18,30-dibenzyl-12,24-diisobutyl-9,27-diisopropyl-2,2,6,11,17,23,26-heptamethyl-33-(methyl((S)-1-oxo-1-(((S)-1-oxo-1-(piperidin-1-yl)propan-2-yl)amino)-3-phenylpropan-2-yl)carbamoyl)-4,7,10,13,16,19,22,25,28,31-decaoxo-15-((R)-1-(trityloxy)ethyl)-3-oxa-5,8,11,14,17,20,23,26,29,32-decaazapentatriacontan-35-oate (Compound P-138) (53.8 mg, 80%).
Workup
- concentrationThe reaction solution was then concentrated under reduced pressure
- custompurified by reverse phase silica gel column chromatography (10 mM aqueous ammonium acetate solution/methanol=70/30→0/100)
Sources & evidence
- ORD record
- ord-452d4f10fbc649eb9a411ddd1a39a591
- Source dataset
- uspto-grants-2016_08
- Patent number
- US09409952B2
Reaction notes
Loading…